There is a growing use of novel psychoactive substances containing synthetic cannabinoids.
Synthetic cannabinoid products have effects similar to those of natural cannabis, yet, these …

As part of an increasing worldwide use of designer drugs, recent use of compounds
containing cathinones and synthetic cannabinoids is especially prevalent. Here, we …

Substance use disorders (SUDs) are characterized by a compulsion to seek and consume
one or more substances of abuse, with a perceived loss of control and a negative emotional …

Impairments in response inhibition and salience attribution (iRISA) have been proposed to
underlie the clinical symptoms of drug addiction as mediated by cortico-striatal-thalamo …

Cannabis use peaks in adolescence, and adolescents may be more vulnerable to the neural
effects of cannabis and cannabis-related harms due to ongoing brain development during …

Cannabis and cannabinoid-based products are increasingly being accepted and
commodified globally. Yet there is currently limited understanding of the effect of the varied …

Background: Synthetic Cannabinoids (SC) are the widest and most diffused class of Novel
Psychoactive Substances. The short-and long-term health risks associated with the …

Over the last decade, new psychoactive substances (NPS) have continuously been the
focus of the international society since their emergence on the illicit drug market. NPS can …

The endocannabinoid system receptors, cannabinoid receptors type-1 (CBR-1) and− 2
(CBR-2), are implicated in several behavioral and cognitive processes. Many studies have …

The increased frequency of risk taking behavior combined with marked neuromaturation has
positioned adolescence as a focal point of research into the neural causes and …